66 related articles for article (PubMed ID: 1971209)
1. Relationship of DNA ploidy to chemoresistance of tumors as measured by in vitro tests.
Volm M; Efferth T
Cytometry; 1990; 11(3):406-10. PubMed ID: 1971209
[TBL] [Abstract][Full Text] [Related]
2. Prognostic relevance of ploidy, proliferation, and resistance-predictive tests in ovarian carcinoma.
Volm M; Brüggemann A; Günther M; Kleine W; Pfleiderer A; Vogt-Schaden M
Cancer Res; 1985 Oct; 45(10):5180-5. PubMed ID: 4027994
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneity of drug resistance in human breast and ovarian cancers.
Kern DH
Cancer J Sci Am; 1998; 4(1):41-5. PubMed ID: 9467045
[TBL] [Abstract][Full Text] [Related]
4. Use of tritiated nucleotide incorporation for prediction of sensitivity of tumors to cytostatic agents.
Volm M
Behring Inst Mitt; 1984 May; (74):273-84. PubMed ID: 6383325
[TBL] [Abstract][Full Text] [Related]
5. Flow cytometry vs. Ki67 labelling index in breast cancer: a prospective evaluation of 181 cases.
Martínez-Arribas F; Núñez MJ; Piqueras V; Lucas AR; Sánchez J; Tejerina A; Schneider J
Anticancer Res; 2002; 22(1A):295-8. PubMed ID: 12017306
[TBL] [Abstract][Full Text] [Related]
6. Non-P-glycoprotein mediated mechanism for multidrug resistance precedes P-glycoprotein expression during in vitro selection for doxorubicin resistance in a human lung cancer cell line.
Baas F; Jongsma AP; Broxterman HJ; Arceci RJ; Housman D; Scheffer GL; Riethorst A; van Groenigen M; Nieuwint AW; Joenje H
Cancer Res; 1990 Sep; 50(17):5392-8. PubMed ID: 1974823
[TBL] [Abstract][Full Text] [Related]
7. Intrinsic drug resistance in a human lung carcinoma xenograft is associated with overexpression of multidrug-resistance DNA-sequences and of plasma membrane glycoproteins.
Volm M; Bak M; Mattern J
Arzneimittelforschung; 1988 Aug; 38(8):1189-93. PubMed ID: 3196414
[TBL] [Abstract][Full Text] [Related]
8. Reversing drug resistance in the ovarian carcinoma cell line SKOV3/mdr1 in vitro by antisense oligodeoxynucleotides.
Pan L; Tong Y; Jin Y; Zhou S; Zhang Y; Yang X; Mao N
Chin Med J (Engl); 2001 Sep; 114(9):929-32. PubMed ID: 11780384
[TBL] [Abstract][Full Text] [Related]
9. Cellular predictive factors for the drug response of lung cancer.
Volm M; Rittgen W
Anticancer Res; 2000; 20(5B):3449-58. PubMed ID: 11131647
[TBL] [Abstract][Full Text] [Related]
10. Expression of protein kinase C in human renal cell carcinoma cells with inherent resistance to doxorubicin.
Efferth T; Volm M
Anticancer Res; 1992; 12(6B):2209-11. PubMed ID: 1363517
[TBL] [Abstract][Full Text] [Related]
11. Flow cytometric DNA-ploidy and proliferative activity of diethylnitrosamine-induced hepatocellular carcinoma and pulmonary metastases in monkeys.
Lapis K; Bocsi J; Lapis P; Thorgeirsson UP
Hepatology; 1995 Sep; 22(3):952-61. PubMed ID: 7657303
[TBL] [Abstract][Full Text] [Related]
12. Cell proliferation in ovarian carcinoma: superior accuracy of S-phase fraction (SPF) by DNA labeling index versus flow cytometric SPF, lack of independent prognostic power for SPF and DNA ploidy, and limited effect of SPF on tumor growth rate.
Meyer JS; Gersell DJ; Yim S
Gynecol Oncol; 2001 Jun; 81(3):466-76. PubMed ID: 11371140
[TBL] [Abstract][Full Text] [Related]
13. Associated expression of protein kinase C with resistance to doxorubicin in human lung cancer.
Volm M; Pommerenke EW
Anticancer Res; 1995; 15(2):463-6. PubMed ID: 7763022
[TBL] [Abstract][Full Text] [Related]
14. A sensitive method for immunocytochemical detection of P-glycoprotein in multidrug-resistant human ovarian carcinoma cell lines.
Chan HS; Bradley G; Thorner P; Haddad G; Gallie BL; Ling V
Lab Invest; 1988 Dec; 59(6):870-5. PubMed ID: 2904510
[TBL] [Abstract][Full Text] [Related]
15. Expression of multidrug resistance gene and localization of P-glycoprotein in human primary ovarian cancer.
Arao S; Suwa H; Mandai M; Tashiro H; Miyazaki K; Okamura H; Nomura H; Hiai H; Fukumoto M
Cancer Res; 1994 Mar; 54(5):1355-9. PubMed ID: 7509719
[TBL] [Abstract][Full Text] [Related]
16. P-glycoprotein expression in ovarian cancer cell line following treatment with cisplatin.
Yang X; Pagé M
Oncol Res; 1995; 7(12):619-24. PubMed ID: 8704279
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of in vitro extreme chemotherapy resistance in resected nonsmall-cell lung cancer.
d'Amato TA; Landreneau RJ; McKenna RJ; Santos RS; Parker RJ
Ann Thorac Surg; 2006 Feb; 81(2):440-6; discussion 446-7. PubMed ID: 16427828
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1alpha gene.
Song X; Liu X; Chi W; Liu Y; Wei L; Wang X; Yu J
Cancer Chemother Pharmacol; 2006 Dec; 58(6):776-84. PubMed ID: 16532342
[TBL] [Abstract][Full Text] [Related]
19. DNA ploidy is a valuable predictor for prognosis of patients with resected renal cell carcinoma.
Abou-Rebyeh H; Borgmann V; Nagel R; Al-Abadi H
Cancer; 2001 Nov; 92(9):2280-5. PubMed ID: 11745282
[TBL] [Abstract][Full Text] [Related]
20. Cell viability assay for drug testing in ovarian cancer: in vitro kill versus clinical response.
Ness RB; Wisniewski SR; Eng H; Christopherson W
Anticancer Res; 2002; 22(2B):1145-9. PubMed ID: 12168915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
